메뉴 건너뛰기




Volumn 53, Issue 12, 2004, Pages 959-969

Pulmonary arterial hypertension: Newer treatment are improving outcomes

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; ANOREXIGENIC AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DEXFENFLURAMINE; DIGOXIN; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; FENFLURAMINE; ILOPROST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; SILDENAFIL; SITAXSENTAN; TADALAFIL; UNIPROST; VARDENAFIL; VASODILATOR AGENT; WARFARIN;

EID: 10044245964     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (59)
  • 1
    • 2942522878 scopus 로고    scopus 로고
    • Clinical classification of pulmonary hypertension
    • Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S.
    • (2004) J Am Coll Cardiol , vol.43
    • Simonneau, G.1    Galie, N.2    Rubin, L.J.3
  • 2
    • 0032578279 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998; 352:719-725.
    • (1998) Lancet , vol.352 , pp. 719-725
    • Gaine, S.P.1    Rubin, L.J.2
  • 3
    • 17144452827 scopus 로고    scopus 로고
    • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial
    • Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000; 132:425-434.
    • (2000) Ann Intern Med , vol.132 , pp. 425-434
    • Badesch, D.B.1    Tapson, V.F.2    McGoon, M.D.3
  • 4
    • 0033551155 scopus 로고    scopus 로고
    • Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects
    • Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99:1858-1865.
    • (1999) Circulation , vol.99 , pp. 1858-1865
    • Rosenzweig, E.B.1    Kerstein, D.2    Barst, R.J.3
  • 5
    • 0033547771 scopus 로고    scopus 로고
    • Aminorex to fen/phen: An epidemic foretold
    • Fishman AP. Aminorex to fen/phen: an epidemic foretold. Circulation 1999; 99:156-161.
    • (1999) Circulation , vol.99 , pp. 156-161
    • Fishman, A.P.1
  • 6
    • 0020640953 scopus 로고
    • Primary pulmonary hypertension and cirrhosis: Are they related?
    • McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 1983; 127:437-441.
    • (1983) Am Rev Respir Dis , vol.127 , pp. 437-441
    • McDonnell, P.J.1    Toye, P.A.2    Hutchins, G.M.3
  • 7
    • 0030463427 scopus 로고    scopus 로고
    • Prevalence of pulmonary hypertension in limited and diffuse scleroderma
    • Battle RW, Davitt MA, Cooper SM, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110:1515-1519.
    • (1996) Chest , vol.110 , pp. 1515-1519
    • Battle, R.W.1    Davitt, M.A.2    Cooper, S.M.3
  • 8
    • 0022600374 scopus 로고
    • Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
    • Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29:515-524.
    • (1986) Arthritis Rheum , vol.29 , pp. 515-524
    • Stupi, A.M.1    Steen, V.D.2    Owens, G.R.3
  • 9
    • 0025016263 scopus 로고
    • Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients
    • Asherson RA, Higenbottam TW, Dinh Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990; 17:1292-1298.
    • (1990) J Rheumatol , vol.17 , pp. 1292-1298
    • Asherson, R.A.1    Higenbottam, T.W.2    Dinh Xuan, A.T.3
  • 10
    • 0032470005 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic lupus erythematosus
    • Shen JY, Chen SL, Wu YX, et al. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int 1999; 18:147-151.
    • (1999) Rheumatol Int , vol.18 , pp. 147-151
    • Shen, J.Y.1    Chen, S.L.2    Wu, Y.X.3
  • 11
    • 0034502422 scopus 로고    scopus 로고
    • Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients
    • Dawson JK, Goodson NG, Graham DR, et al. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 2000; 39:1320-1325.
    • (2000) Rheumatology (Oxford) , vol.39 , pp. 1320-1325
    • Dawson, J.K.1    Goodson, N.G.2    Graham, D.R.3
  • 12
    • 0033789708 scopus 로고    scopus 로고
    • HIV-Related pulmonary hypertension: Analytic review of 131 cases
    • Mehta KJ, Khan IA, Mehta RN, et al. HIV-Related pulmonary hypertension: analytic review of 131 cases. Chest 2000; 118:1133-1141.
    • (2000) Chest , vol.118 , pp. 1133-1141
    • Mehta, K.J.1    Khan, I.A.2    Mehta, R.N.3
  • 13
    • 0038555346 scopus 로고    scopus 로고
    • Pulmonary hypertension in patients with end-stage renal disease
    • Yigla M, Nakhoul F, Sabag A, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123:1577-1582.
    • (2003) Chest , vol.123 , pp. 1577-1582
    • Yigla, M.1    Nakhoul, F.2    Sabag, A.3
  • 14
    • 0023615359 scopus 로고
    • Primary pulmonary hypertension. A national prospective study
    • Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107:216-223.
    • (1987) Ann Intern Med , vol.107 , pp. 216-223
    • Rich, S.1    Dantzker, D.R.2    Ayres, S.M.3
  • 15
    • 0030841153 scopus 로고    scopus 로고
    • Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
    • Denton CP, Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36:239-243.
    • (1997) Br J Rheumatol , vol.36 , pp. 239-243
    • Denton, C.P.1    Cailes, J.B.2    Phillips, G.D.3
  • 16
    • 0037151645 scopus 로고    scopus 로고
    • Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
    • Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cordiol 2002; 40:780-788.
    • (2002) J Am Coll Cordiol , vol.40 , pp. 780-788
    • Sitbon, O.1    Humbert, M.2    Nunes, H.3
  • 17
    • 0037126044 scopus 로고    scopus 로고
    • Survival in primary pulmonary hypertension: The impact of epoprostenol therapy
    • McLaughlin VV; Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106:1477-1482.
    • (2002) Circulation , vol.106 , pp. 1477-1482
    • McLaughlin, V.V.1    Shillington, A.2    Rich, S.3
  • 18
    • 0027209130 scopus 로고
    • Primary pulmonary hypertension in a patient with systemic lupus erythematosus: Partial improvement with cyclophosphamide
    • Groen H, Bootsma H, Postma DS, et al. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol 1993; 20:1055-1057.
    • (1993) J Rheumatol , vol.20 , pp. 1055-1057
    • Groen, H.1    Bootsma, H.2    Postma, D.S.3
  • 19
    • 0028967676 scopus 로고
    • Effect of n-BiPAP therapy on the hemodynamics in patients with central sleep apnea
    • Thalhofer S, Dorow P. [Effect of n-BiPAP therapy on the hemodynamics in patients with central sleep apnea]. Pneumologie 1995; 49 Suppl 1:165-166.
    • (1995) Pneumologie , vol.49 , Issue.1 SUPPL. , pp. 165-166
    • Thalhofer, S.1    Dorow, P.2
  • 20
    • 0020625012 scopus 로고
    • Fatal outcome following nifedipine for pulmonary hypertension
    • Farber HW, Karlinsky P, Faling LJ. Fatal outcome following nifedipine for pulmonary hypertension. Chest 1983; 83:708-709.
    • (1983) Chest , vol.83 , pp. 708-709
    • Farber, H.W.1    Karlinsky, P.2    Faling, L.J.3
  • 21
    • 0031051347 scopus 로고    scopus 로고
    • The effect of digoxin on mortality and morbidity in patients with heart failure
    • The Digitalis Investigation Group
    • The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997; 336:525-533.
    • (1997) N Engl J Med , vol.336 , pp. 525-533
  • 22
    • 0031719459 scopus 로고    scopus 로고
    • The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension
    • Rich S, Seidlitz M, Dodin E, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998; 114:787-792.
    • (1998) Chest , vol.114 , pp. 787-792
    • Rich, S.1    Seidlitz, M.2    Dodin, E.3
  • 23
    • 0030813510 scopus 로고    scopus 로고
    • The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension
    • Frank H, Mlczoch J, Huber K, et al. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997; 112:714-721.
    • (1997) Chest , vol.112 , pp. 714-721
    • Frank, H.1    Mlczoch, J.2    Huber, K.3
  • 24
    • 0026632785 scopus 로고
    • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81.
    • (1992) N Engl J Med , vol.327 , pp. 76-81
    • Rich, S.1    Kaufmann, E.2    Levy, P.S.3
  • 25
    • 0033213243 scopus 로고    scopus 로고
    • The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension
    • Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 1999; 34:1184-1187.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1184-1187
    • Rich, S.1    McLaughlin, V.V.2
  • 26
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    • The Primary Pulmonary Hypertension Study Group
    • Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996; 334:296-302.
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3
  • 27
    • 10044270160 scopus 로고    scopus 로고
    • Chronic infusion of Treprostinil is safe, and appears to prolong survival over a three-year period in patients with Pulmonary Arterial Hypertension
    • Abstract presented
    • Gibbs J, Arneson C, Mottola D. Chronic infusion of Treprostinil is safe, and appears to prolong survival over a three-year period in patients with Pulmonary Arterial Hypertension. Abstract presented at American Thoracic Society Meeting, 2003.
    • (2003) American Thoracic Society Meeting
    • Gibbs, J.1    Arneson, C.2    Mottola, D.3
  • 28
    • 0032576672 scopus 로고    scopus 로고
    • Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
    • McLaughlin VV, Genthner DE, Panella MM, et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998; 338:273-277.
    • (1998) N Engl J Med , vol.338 , pp. 273-277
    • McLaughlin, V.V.1    Genthner, D.E.2    Panella, M.M.3
  • 29
  • 30
    • 0037086133 scopus 로고    scopus 로고
    • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial
    • Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002; 165:800-804.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 800-804
    • Simonneau, G.1    Barst, R.J.2    Galie, N.3
  • 31
    • 0038826796 scopus 로고    scopus 로고
    • Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost
    • Fruhwald FM, Kjellstrom B, Perthold W, et al. Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost. Chest 2003; 124:351-359.
    • (2003) Chest , vol.124 , pp. 351-359
    • Fruhwald, F.M.1    Kjellstrom, B.2    Perthold, W.3
  • 32
    • 0027324745 scopus 로고
    • Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
    • Giaid A, Tanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-1739.
    • (1993) N Engl J Med , vol.328 , pp. 1732-1739
    • Giaid, A.1    Tanagisawa, M.2    Langleben, D.3
  • 33
    • 0035171979 scopus 로고    scopus 로고
    • Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension
    • Rubens C, Ewert R, Halank M, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001; 120:1562-1569.
    • (2001) Chest , vol.120 , pp. 1562-1569
    • Rubens, C.1    Ewert, R.2    Halank, M.3
  • 34
    • 0032588933 scopus 로고    scopus 로고
    • Does blockade of endothelinB1-receptor activation increase endothelinB2/endothelinA receptor-mediated constriction in the rabbit basilar artery?
    • Zuccarello M, Boccaletti R, Rapoport RM. Does blockade of endothelinB1-receptor activation increase endothelinB2/endothelinA receptor-mediated constriction in the rabbit basilar artery? J Cardiovasc Phamacol 1999; 33:679-684.
    • (1999) J Cardiovasc Phamacol , vol.33 , pp. 679-684
    • Zuccarello, M.1    Boccaletti, R.2    Rapoport, R.M.3
  • 35
    • 0035818316 scopus 로고    scopus 로고
    • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study
    • Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001; 358:1119-1123.
    • (2001) Lancet , vol.358 , pp. 1119-1123
    • Channick, R.N.1    Simonneau, G.2    Sitbon, O.3
  • 36
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346:896-903.
    • (2002) N Engl J Med , vol.346 , pp. 896-903
    • Rubin, L.J.1    Badesch, D.B.2    Barst, R.J.3
  • 37
    • 0025837793 scopus 로고
    • Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
    • D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115:343-349.
    • (1991) Ann Intern Med , vol.115 , pp. 343-349
    • D'Alonzo, G.E.1    Barst, R.J.2    Ayres, S.M.3
  • 38
    • 0344406959 scopus 로고    scopus 로고
    • Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    • Barst RJ, Ivy D, Dingemanse J, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003; 73:372-382.
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 372-382
    • Barst, R.J.1    Ivy, D.2    Dingemanse, J.3
  • 39
    • 10044223726 scopus 로고    scopus 로고
    • Package insert. Tracleer (bosentan)
    • South San Francisco, Calif
    • Actelion Pharmaceuticals. Package insert. Tracleer (bosentan). Physician's Desk Reference (www.pdr.net). South San Francisco, Calif, 2002.
    • (2002) Physician's Desk Reference
  • 40
    • 1842530387 scopus 로고    scopus 로고
    • Clinical efficacy of sildenafu in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study
    • Sastry BK, Narasimhan C, Reddy NK, et al. Clinical efficacy of sildenafu in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cordiol 2004; 43:1149-1153.
    • (2004) J Am Coll Cordiol , vol.43 , pp. 1149-1153
    • Sastry, B.K.1    Narasimhan, C.2    Reddy, N.K.3
  • 42
    • 0037389118 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    • Stiebellehner L, Petkov V, Vonbank K, et al. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 2003; 123:1293-1295.
    • (2003) Chest , vol.123 , pp. 1293-1295
    • Stiebellehner, L.1    Petkov, V.2    Vonbank, K.3
  • 43
    • 0035145373 scopus 로고    scopus 로고
    • Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase
    • Behn D, Potter MJ. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001; 42:523-527.
    • (2001) Invest Ophthalmol Vis Sci , vol.42 , pp. 523-527
    • Behn, D.1    Potter, M.J.2
  • 44
    • 0031031440 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336:111-117.
    • (1997) N Engl J Med , vol.336 , pp. 111-117
    • Rubin, L.J.1
  • 45
    • 0031844138 scopus 로고    scopus 로고
    • The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation
    • Conte JV, Gaine SP, Orens JB, et al. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. J Heart Lung Transplant 1998; 17:679-685.
    • (1998) J Heart Lung Transplant , vol.17 , pp. 679-685
    • Conte, J.V.1    Gaine, S.P.2    Orens, J.B.3
  • 46
    • 0032038497 scopus 로고    scopus 로고
    • Lung transplantation for pulmonary hypertension: Patient selection and maintenance therapy while awaiting transplantation
    • Rich S, McLaughlin VV. Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation. Semin Thorac Cardiovasc Surg 1998; 10:135-138.
    • (1998) Semin Thorac Cardiovasc Surg , vol.10 , pp. 135-138
    • Rich, S.1    McLaughlin, V.V.2
  • 47
    • 0031817985 scopus 로고    scopus 로고
    • International guidelines for the selection of lung transplant candidates
    • The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society
    • Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 1998; 17:703-709.
    • (1998) J Heart Lung Transplant , vol.17 , pp. 703-709
    • Maurer, J.R.1    Frost, A.E.2    Estenne, M.3
  • 48
    • 0034963691 scopus 로고    scopus 로고
    • Severe pulmonary hypertension: Critical care clinics
    • McLaughlin VV, Rich S. Severe pulmonary hypertension: critical care clinics. Crit Care Clin 2001; 17:453-467.
    • (2001) Crit Care Clin , vol.17 , pp. 453-467
    • McLaughlin, V.V.1    Rich, S.2
  • 49
    • 0032808998 scopus 로고    scopus 로고
    • The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
    • Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report - 1999. J Heart Lung Transplant 1999; 18:611-626.
    • (1999) J Heart Lung Transplant , vol.18 , pp. 611-626
    • Hosenpud, J.D.1    Bennett, L.E.2    Keck, B.M.3
  • 50
    • 0038461997 scopus 로고    scopus 로고
    • The registry of the International Society for Heart and Lung Transplantation: Introduction to the Twentieth Annual Reports - 2003
    • Hertz MI, Mohacsi PJ, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: introduction to the Twentieth Annual Reports - 2003. J Heart Lung Transplant 2003; 22:610-615.
    • (2003) J Heart Lung Transplant , vol.22 , pp. 610-615
    • Hertz, M.I.1    Mohacsi, P.J.2    Taylor, D.O.3
  • 52
    • 0032145492 scopus 로고    scopus 로고
    • Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment
    • Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998; 32:297-304.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 297-304
    • Sandoval, J.1    Gaspar, J.2    Pulido, T.3
  • 53
    • 0041829193 scopus 로고    scopus 로고
    • Atrial septostomy in the treatment of severe pulmonary arterial hypertension
    • Reichenberger F, Pepke-Zaba J, McNeil K, et al. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax 2003; 58:797-800.
    • (2003) Thorax , vol.58 , pp. 797-800
    • Reichenberger, F.1    Pepke-Zaba, J.2    McNeil, K.3
  • 54
    • 0025999492 scopus 로고
    • Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease
    • Nihill MR, O'Laughlin MP, Mullins CE. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diagn 1991; 24:166-172.
    • (1991) Cathet Cardiovasc Diagn , vol.24 , pp. 166-172
    • Nihill, M.R.1    O'Laughlin, M.P.2    Mullins, C.E.3
  • 55
    • 0037868048 scopus 로고    scopus 로고
    • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
    • Ghofrani HA, Rose F, Schermuly RT, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003; 42:158-164.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 158-164
    • Ghofrani, H.A.1    Rose, F.2    Schermuly, R.T.3
  • 56
    • 0037163478 scopus 로고    scopus 로고
    • Pulmonary hypertension: Hemodynamic diagnosis and management
    • Chatterjee K, De Marco T, Alpert JS. Pulmonary hypertension: hemodynamic diagnosis and management. Arch Intern Med 2002; 162:1925-1933.
    • (2002) Arch Intern Med , vol.162 , pp. 1925-1933
    • Chatterjee, K.1    De Marco, T.2    Alpert, J.S.3
  • 57
    • 0028282859 scopus 로고
    • Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
    • Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144:275-285.
    • (1994) Am J Pathol , vol.144 , pp. 275-285
    • Tuder, R.M.1    Groves, B.2    Badesch, D.B.3
  • 58
    • 0037361987 scopus 로고    scopus 로고
    • Advances in the treatment of secondary pulmonary hypertension
    • Maloney JP. Advances in the treatment of secondary pulmonary hypertension. Curr Opin Pulm Med 2003; 9:139-143.
    • (2003) Curr Opin Pulm Med , vol.9 , pp. 139-143
    • Maloney, J.P.1
  • 59
    • 2942544581 scopus 로고    scopus 로고
    • Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
    • Galie N, Seeger W, Naeije R, et al. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:81S-88S.
    • (2004) J Am Coll Cardiol , vol.43
    • Galie, N.1    Seeger, W.2    Naeije, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.